NCT01196117 - Sleepiness and the Effects of CPAP on Salivary Cortisol and Alpha-Amylase Levels in Patients With Sleep Apnea | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 15, 2004

Primary Completion Date

December 15, 2011

Study Completion Date

December 15, 2011

Conditions

Sleep ApneaSleep Disordered Breathing

Interventions

DEVICE

14 days of placebo therapy

14 days of placebo therapy - use of guaifenesin with salivary cortisol measurement and Epworth Sleepiness Score (ESS) documentation

DEVICE

14 days of CPAP therapy

14 days of continuous positive airway pressure (CPAP) therapy with salivary cortisol measurement and Epworth Sleepiness Score (ESS) documentation

Trial Locations (1)

Froedtert West Clinics - Otolaryngology Clinc, Milwaukee